Resultats de la cerca - Rachel Doherty

  • Mostrar 1 - 4 resultats de 4
Refinar resultats
  1. 1
    Photodynamic killing of cancer cells by a Platinum(II) complex with cyclometallating ligand

    Photodynamic killing of cancer cells by a Platinum(II) complex with cyclometallating ligand per Rachel Doherty, Igor V. Sazanovich, Luke K. McKenzie, Alexander S. Stasheuski, Rachel Coyle, Elizabeth Baggaley, Sarah Bottomley, Julia A. Weinstein, Helen E. Bryant

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer

    Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer per Arvind Arora, Tarek M. Abdel-Fatah, Devika Agarwal, Rachel Doherty, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Alaa T. Alshareeda, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

    Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer per Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora, Devika Agarwal, Tao Chen, Paul M. Moseley, Christina J. Perry, Rachel Doherty, Stephen Chan, Andrew R. Green, Emad A. Rakha, Graham Ball, Ian O. Ellis, Nicola J. Curtin, Srinivasan Madhusudan

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy

    Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy per Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty, Roslin Russell, Devika Agarwal, Paul M. Moseley, Christina J. Perry, Arvind Arora, Nouf H. Alsubhi, Claire Seedhouse, Emad A. Rakha, Andrew R. Green, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, Srinivasan Madhusudan

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: